AIRA
Overview
AIRA is an AI platform designed for clinical development, focusing on study design and protocol development. It serves biopharma teams, early clinical biotechs, biopharma sponsors, CROs, and service providers involved in bringing treatments to patients.
- What it does: AIRA functions as a unified AI platform that integrates expert-level clinical, regulatory, and medical writing AI thought partners. It assists teams in collaborating on study context, drafting protocols, and identifying regulatory risks.
- How it fits a clinical or practice workflow: AIRA supports the entire clinical development workflow, from program strategy planning and protocol drafting to generating IND submission documents. It provides intelligence grounded in traceable evidence, develops compliant study document drafts, offers evidence-backed recommendations and document reviews, and maintains context awareness across evolving study information.
- Notable capabilities: The platform offers intelligence by analyzing questions within the full study context, applying clinical and regulatory reasoning, and grounding answers in guidelines and curated data. It also features authoring capabilities to generate protocol drafts and implement changes with medical writing expertise. Additionally, AIRA provides insights and review functions, including continuous regulatory and feasibility checks, flagging risks, and recommending resolutions. Its context awareness connects and synthesizes study information to suggest next steps and prevent misalignment.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Key Features
- Expert-level clinical, regulatory, and medical writing AI thought partners
- 40% faster submission cycle
- Save $150K+ to millions per study
- Prevent up to 50% of amendments
- Collaborate without chaos
- Make confident, defensible decisions
- Protocol drafting to regulatory risk flags
- No AI training on any confidential data
- Provides clinical trial intelligence grounded in traceable evidence and expert reasoning
- Develops compliant study document drafts and implements changes
Use Cases
- Study design
- Protocol development
- Regulatory submission package development
- Program strategy planning
- IND submission document drafting
- Clinical development workflow acceleration
What Physicians Need to Know
AIRA can significantly accelerate protocol development and regulatory submission processes by providing expert-grade clinical and regulatory reasoning, identifying relevant evidence, and flagging potential risks early. Physicians involved in clinical development can leverage AIRA to make more confident, defensible study design decisions and streamline the drafting of regulatory documents.
The provided text does not specify any direct integrations with other software or platforms. It highlights AIRA as a unified AI platform for clinical development.
Details
| Category | Drug Discovery & Research |
| Pricing | Unknown |
| Compliance | |
| BAA Available | Unknown |
| HIPAA Compliant | Yes AI-estimated |
| FDA Status | Unknown |
| Integrations | |
| EHR | Not specified |
| Specialties | Hematology, Internal Medicine, Oncology |
Ratings & Reviews
No reviews yet. Be the first to review this tool!





